Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
Coxiella burnetii | Injection | 50 microgram/mL | Current | Limited Availability | Manufacturing | 9/08/2024 |
lisinopril dihydrate | Tablet, uncoated | 10.89 mg | Current | Unavailable | Manufacturing | 9/08/2024 |
duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Current | Limited Availability | Manufacturing | 9/08/2024 |
sodium fluoride | Injection, concentrated | 1 mg/mL | Resolved | Available | Manufacturing | 9/08/2024 |
Omalizumab | Injection, solution | 150 mg | Current | Emergency Supply Only | Manufacturing | 9/08/2024 |
metformin hydrochloride | Tablet, modified release | 1000 mg | Resolved | Available | Manufacturing | 9/08/2024 |
tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 9/08/2024 |
betahistine dihydrochloride | Tablet, uncoated | 16 mg | Discontinued | Unavailable | Manufacturing | 9/08/2024 |
acarbose | Tablet | 50 mg | Anticipated | Available | Manufacturing | 9/08/2024 |
mesalazine | Tablet, enteric coated | 800 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 9/08/2024 |
ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 9/08/2024 |
tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 9/08/2024 |
cinacalcet hydrochloride | Tablet | 66.127 mg | Current | Unavailable | Manufacturing | 9/08/2024 |
dasatinib | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 9/08/2024 |
escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Commercial Changes / Commercial viability | 9/08/2024 |
amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide | Tablet, film coated | 6.95 mg~40 mg~25 mg | Current | Unavailable | Manufacturing | 9/08/2024 |
hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 12.5 mg~6.95 mg~40 mg | Current | Limited Availability | Manufacturing | 9/08/2024 |
gefitinib | Tablet, film coated | 250 mg | Current | Unavailable | Product recall | 9/08/2024 |
lacosamide | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 9/08/2024 |
atovaquone~proguanil hydrochloride | Tablet, film coated | 62.5 mg~25 mg | Resolved | Available | Manufacturing | 9/08/2024 |
fluoxetine hydrochloride | Capsule, hard | 22.36 mg | Resolved | Available | Manufacturing | 9/08/2024 |
cabergoline | Tablet, uncoated | 2 mg | Anticipated | Available | Manufacturing | 9/08/2024 |
desonide | Lotion | .5 mg/g | Resolved | Available | Manufacturing | 9/08/2024 |
rizatriptan benzoate | Wafer | 14.53 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 9/08/2024 |
sodium oxidronate | Injection, powder for | 3.15 mg | Resolved | Available | Manufacturing | 9/08/2024 |
methylphenidate hydrochloride | Tablet, modified release | 18 mg | Anticipated | Available | Manufacturing | 9/08/2024 |
zopiclone | Tablet, film coated | 7.5 mg | Current | Unavailable | Manufacturing | 9/08/2024 |
bicalutamide | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 8/08/2024 |
adrenaline (epinephrine) acid tartrate | Injection, solution | 182 microgram/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/08/2024 |
temozolomide | Capsule, hard | 100 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 8/08/2024 |
tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 8/08/2024 |
tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 8/08/2024 |
tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 8/08/2024 |
adrenaline (epinephrine) acid tartrate | Injection, solution | 1.819 mg | Current | Unavailable | Manufacturing | 8/08/2024 |
teriflunomide | Tablet, film coated | 14 mg | Anticipated | Available | Manufacturing | 8/08/2024 |
olanzapine | Tablet, uncoated | 7.5 mg | Resolved | Available | Manufacturing | 8/08/2024 |
Bevacizumab | Injection, concentrated | 25 mg/mL | Anticipated | Available | Commercial Changes / Commercial viability | 8/08/2024 |
sitagliptin fumarate | Tablet, film coated | 64.249 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 8/08/2024 |
sodium valproate | Tablet, enteric coated | 500 mg | Anticipated | Available | Manufacturing | 8/08/2024 |
fluorouracil | Injection, solution | 50 mg/mL | Current | Limited Availability | Manufacturing | 8/08/2024 |
clarithromycin | Oral Liquid, powder for | 50 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 8/08/2024 |
nizatidine | Capsule, hard | 300 mg | Anticipated | Available | Manufacturing | 8/08/2024 |
roxithromycin | Tablet, film coated | 150 mg | Discontinued | Unavailable | Manufacturing | 8/08/2024 |
roxithromycin | Tablet, film coated | 300 mg | Discontinued | Unavailable | Manufacturing | 8/08/2024 |
framycetin sulfate~gramicidin~dexamethasone | Ear Drops | 5 mg/mL~.05 mg/mL~.5 mg/mL | Current | Unavailable | Manufacturing | 7/08/2024 |
fluorouracil | Cream | 50 mg/g | Resolved | Available | Manufacturing | 7/08/2024 |
ketorolac trometamol | Injection, solution | 30 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/08/2024 |
risperidone | Tablet | .5 mg | Current | Unavailable | Manufacturing | 7/08/2024 |
risperidone | Tablet | 1 mg | Current | Unavailable | Manufacturing | 7/08/2024 |
prochlorperazine maleate | Tablet | 5 mg | Resolved | Available | Manufacturing | 7/08/2024 |
tamsulosin hydrochloride~dutasteride | Capsule, modified release | 400 microgram~500 microgram | Current | Unavailable | Manufacturing | 7/08/2024 |
fentanyl | Drug delivery system, transdermal | 10.2 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 7/08/2024 |
ondansetron | Tablet, orally disintegrating | 4 mg | Resolved | Available | Manufacturing | 7/08/2024 |
mycophenolate mofetil | Capsule, hard | 250 mg | Discontinued | Unavailable | Manufacturing | 7/08/2024 |
sildenafil citrate | Tablet, film coated | 28.1 mg | Resolved | Available | Manufacturing | 7/08/2024 |
escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 7/08/2024 |
escitalopram oxalate | Tablet, film coated | 25.47 mg | Current | Unavailable | Manufacturing | 7/08/2024 |
Abatacept | Injection | 125.875 mg | Resolved | Available | Manufacturing | 7/08/2024 |
ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/08/2024 |
imatinib mesilate | Capsule, hard | 119.47 mg | Resolved | Available | Manufacturing | 7/08/2024 |
clonidine hydrochloride | Tablet | 100 microgram | Anticipated | Available | Unexpected increase in consumer demand | 7/08/2024 |
tadalafil | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 7/08/2024 |
tadalafil | Tablet, film coated | 20 mg | Current | Unavailable | Manufacturing | 7/08/2024 |
ephedrine hydrochloride | Injection, solution | 30 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/08/2024 |
nebivolol hydrochloride | Tablet | 5.45 mg | Resolved | Available | Manufacturing | 7/08/2024 |
tamsulosin hydrochloride~dutasteride | Capsule, modified release | 400 microgram~500 microgram | Current | Limited Availability | Manufacturing | 7/08/2024 |
hydrocortisone acetate | Enema | 10 % w/w | Discontinued | Unavailable | Manufacturing | 7/08/2024 |
gramicidin~framycetin sulfate~dexamethasone | Ear Drops | .05 mg/mL~5 mg/mL~.5 mg/mL | Current | Unavailable | Manufacturing | 7/08/2024 |
rifampicin | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 7/08/2024 |
eprosartan mesilate | Tablet, film coated | 735.8 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/08/2024 |
alprostadil | Injection, powder for | 40 microgram/mL | Current | Unavailable | Manufacturing | 7/08/2024 |
sildenafil citrate | Tablet, film coated | 28.09 mg | Current | Limited Availability | Unexpected increase in consumer demand | 6/08/2024 |
ramipril | Tablet, uncoated | 5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/08/2024 |
ramipril | Tablet, uncoated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/08/2024 |
isoniazid | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 6/08/2024 |
prochlorperazine maleate | Tablet | 5 mg | Resolved | Available | Manufacturing | 6/08/2024 |
pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Resolved | Available | Manufacturing | 6/08/2024 |
oseltamivir phosphate | Oral Liquid, powder for | 7.88 mg/mL | Current | Emergency Supply Only | Unexpected increase in consumer demand | 6/08/2024 |
ropivacaine hydrochloride | Injection, solution | 400 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 6/08/2024 |
trandolapril | Capsule, hard | 2 mg | Current | Limited Availability | Manufacturing | 6/08/2024 |
trandolapril | Capsule, hard | 4 mg | Current | Limited Availability | Manufacturing | 6/08/2024 |
efmoroctocog alfa | Injection, powder for | 250 IU | Current | Unavailable | Manufacturing | 6/08/2024 |
tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 6/08/2024 |
tadalafil | Tablet, film coated | 20 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/08/2024 |
latanoprost | Eye Drops, solution | .05 mg/mL | Resolved | Available | Manufacturing | 6/08/2024 |
bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate | Injection, solution | 2.64 mg/mL~4.5 microgram/mL | Current | Limited Availability | Manufacturing | 6/08/2024 |
nebivolol hydrochloride | Tablet | 5.45 mg | Resolved | Available | Manufacturing | 6/08/2024 |
aciclovir | Injection, solution | 25 mg/mL | Current | Unavailable | Manufacturing | 6/08/2024 |
iopromide | Injection, solution | 768.86 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 6/08/2024 |
timolol maleate | Eye Drops, solution | 6.84 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 6/08/2024 |
mianserin hydrochloride | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 6/08/2024 |
estradiol~norethisterone acetate | Drug delivery system, transdermal | .512 mg~4.8 mg | Current | Unavailable | Manufacturing | 6/08/2024 |
alprostadil | Injection, powder for | 20 microgram/mL | Current | Unavailable | Manufacturing | 6/08/2024 |
metformin hydrochloride | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 6/08/2024 |
metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 6/08/2024 |
zoledronic acid monohydrate | Injection, solution | 5.33 mg | Resolved | Available | Manufacturing | 5/08/2024 |
olanzapine pamoate monohydrate | Injection, powder for | 931 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 5/08/2024 |
olanzapine pamoate monohydrate | Injection, powder for | 690 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 5/08/2024 |
olanzapine pamoate monohydrate | Injection, powder for | 483 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 5/08/2024 |
fentanyl | Drug delivery system, transdermal | 5.1 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 5/08/2024 |
fentanyl | Drug delivery system, transdermal | 2.55 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 5/08/2024 |
mirtazapine | Tablet, film coated | 45 mg | Anticipated | Available | Manufacturing | 5/08/2024 |
timolol maleate~dorzolamide hydrochloride | Eye Drops, solution | 6.83 mg/mL~22.26 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 5/08/2024 |
pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Resolved | Available | Manufacturing | 5/08/2024 |
pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Resolved | Available | Manufacturing | 5/08/2024 |
ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~5.198 mg | Current | Limited Availability | Manufacturing | 5/08/2024 |
rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 10.396 mg~10 mg | Current | Limited Availability | Manufacturing | 5/08/2024 |
temozolomide | Capsule, hard | 5 mg | Current | Unavailable | Manufacturing | 5/08/2024 |
rosuvastatin calcium | Tablet, film coated | 10.42 mg | Resolved | Available | Manufacturing | 5/08/2024 |
cefuroxime axetil | Tablet, film coated | 300.715 mg | Current | Limited Availability | Unexpected increase in consumer demand | 5/08/2024 |
mupirocin | Ointment | 20 mg/g | Resolved | Available | Manufacturing | 5/08/2024 |
alfentanil hydrochloride | Injection, solution | 1.09 mg | Resolved | Available | Manufacturing | 5/08/2024 |
montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 5/08/2024 |
montelukast sodium | Tablet, film coated | 10.4 mg | Current | Limited Availability | Unexpected increase in consumer demand | 5/08/2024 |
mycophenolate mofetil | Injection, powder for | 500 mg | Current | Unavailable | Manufacturing | 5/08/2024 |
spironolactone | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 5/08/2024 |
flecainide acetate | Tablet | 50 mg | Current | Unavailable | Manufacturing | 5/08/2024 |
indometacin | Capsule, hard | 25 mg | Current | Limited Availability | Manufacturing | 5/08/2024 |
temozolomide | Capsule, hard | 5 mg | Anticipated | Available | Manufacturing | 5/08/2024 |
raltitrexed | Injection, powder for | 2 mg | Resolved | Available | Unexpected increase in consumer demand | 5/08/2024 |
captopril | Tablet, uncoated | 25 mg | Current | Unavailable | Manufacturing | 5/08/2024 |
captopril | Tablet, uncoated | 50 mg | Current | Unavailable | Manufacturing | 5/08/2024 |
dorzolamide hydrochloride~timolol maleate | Eye Drops, solution | 22.26 mg/mL~6.83 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 5/08/2024 |
flecainide acetate | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 5/08/2024 |
midazolam | Injection, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 5/08/2024 |
2024年8月12日